Company
LON:IMI
IMI PLC, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, cleanly, efficiently and cost effectively.
81 stories · page 3 of 5
Archive
Aside from the oil giant's second-quarter numbers, results are also due from the likes of Centrica, Standard Chartered, Taylor Wimpey, Just Eat, and Greggs
Archive
Aside from the raft of banking numbers in the Week Ahead, the likes of BP, Centrica, Next, Rolls-Royce, BAE Systems and Taylor Wimpey will also continue the FTSE 100 reporting splurge
The US investment bank’s analysts pointed out that IMI “has overshot to the downside, with a derating driven by concerns on PowerGen, short cycle risks & Hydronic execution”
With the Trump-Kim meeting and various pieces of economic data behind us, all eyes are turning to Parliament, which is set to vote on amendments to the EU Withdrawal Bill today and tomorrow
A look at some of the top risers and fallers in London on Monday
Organic revenues for the three months were 2% higher with 3% growth overall
Archive
The day ahead includes quarterly updates from Glencore and Smith & Nephew
Archive
Another busy week of earnings from FTSE 350 companies awaits
Organic revenues will rise a little in the first half of 2018
Proactive takes a look at some movers and shakers throughout the day in London
Investments and investor services
Fears of a trade war have rattled investors, with minerals companies particularly hard hit
Archive
The day ahead includes full year results from the London Stock Exchange, Mondi, Spire Healthcare and IMI
After a bullish run over the past few months, European and US markets endured a rare off day on Thursday
Archive
Will Astra get into the MYSTIC? The company said not all hope was lost for its lung cancer trial, which flunked in the summer
Archive
The week ahead includes earnings from M&S, Sainsbury's, ABF, Direct Line, Wetherspoon and AstraZeneca while macro-economic announcements will be thin on the ground
IMI expects full year 2017 results will be "modestly above" current market expectations
Despite the beating meted out to IMPs and BATs, the Footsie rallied in the last half hour to trim its heavy losses
Archive
Day ahead: First quarter update from BT Group PLC, second quarter results from Barclays PLC ...
Archive
Week ahead: Lloyds, Barclays, AstraZeneca, GlaxoSmithKline, Sky, Reckitt Benckiser
Archive
A glance at some of the stories on the Proactive newswire today
